 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
MS Speaks |
|
***************************************************** |
|
(Abst.) Projected study investigating relationship between fin... |
|
0 replies |
|
Rebound syndrome in MS patients after stopping Gilenya |
|
4 replies |
|
Randomized clinical trial: 2 fingolimod doses vs. Copaxone for... |
|
0 replies |
|
FDA approves first generics of Gilenya |
|
0 replies |
|
Fingolimod and liver injury research information (PubMed) |
|
0 replies |
|
(Abst.) Gilenya vs. Tecfidera in MS... |
|
0 replies |
|
(Abst.) PML after fingolimod treatment |
|
1 replies |
|
Gilenya shows promise in pediatric MS |
|
1 replies |
|
(Abst.) Switching from Tysabri to Gilenya within 6 weeks cuts ... |
|
0 replies |
|
(AAN abst.) Alternate dosing of fingolimod for MS |
|
0 replies |
|
***************************************************** |
|
Next Page |
